Square Pharma to set up subsidiary
Square Pharmaceuticals is set to establish a subsidiary company named Square Lifesciences to manufacture pharmaceuticals oral solid dosage products.
The estimated cost for the subsidiary would be TK 350 crore. The amount would be internally generated, according to a statement.
The plant is expected to be complete by June 2023, the statement added.
Comments